FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Bumetanide Injection, USP
Status: Currently in Shortage
»Date first posted: 12/13/2017
»Therapeutic Categories: Cardiovascular

Expand all

Hospira, Inc. (Revised 10/11/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/4 mL (0.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1412-04) Next Delivery and Estimated Recovery: June 2019 Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter

Other
2.5 mg/10 mL (0.25 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1412-10) Next Delivery: 2019; Estimated Recovery: June 2019 Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter

Other

West-Ward Pharmaceuticals (Revised 09/10/2018)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.25 mg/mL, 4 mL vial (NDC 0641-6008-10) Inventory is currently available. Additional lots are scheduled to be manufactured in the September - October 2018 timeframe. Product will be made available as it is released. Demand increase for the drug
0.25 mg/mL, 10 mL vial (NDC 0641-6007-10) Inventory is currently available. Additional lots are scheduled to be manufactured in the September October 2018 timeframe. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English